+91 789 2456 581 | info@nckpharma.com
Tag

Amgen’s Xgeva gets US FDA approval to treat hypercalcemia of malignancy refractory to bisphosphonate therapy

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests 

etc.